Related Experiment Video

Updated: Feb 4, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.1K

Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis

Makon-Sébastien Njock1, Julien Guiot2,3, Monique A Henket2,3

  • 1Laboratory of Molecular Angiogenesis, GIGA-R, University of Liège, Liège, Belgium.

Thorax
|September 24, 2018
PubMed

Insights

Researchers identified a unique signature of three microRNAs (miRNAs) in sputum exosomes from patients with idiopathic pulmonary fibrosis (IPF). This finding offers potential biomarkers for IPF diagnosis and disease severity assessment.

Area of Science:

  • Pulmonology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a fatal, progressive lung disease with complex diagnosis.
  • Current diagnostic methods for IPF can be challenging and invasive.

Purpose of the Study:

  • To characterize the microRNA (miRNA) content of exosomes derived from sputum in IPF patients.
  • To identify potential non-invasive biomarkers for IPF diagnosis and disease severity.

Main Methods:

  • Utilized miRNA quantitative PCR array to analyze sputum exosomal miRNA levels.
  • Compared miRNA profiles between IPF patients and healthy controls.

Main Results:

  • Identified significant dysregulation of sputum exosomal miRNA levels in IPF patients compared to healthy subjects.
  • Discovered a unique signature of three specific miRNAs associated with IPF.
  • Observed a negative correlation between miR-142-3p and lung diffusing capacity.

Conclusions:

  • This study presents the first characterization of miRNA content in sputum-derived exosomes for IPF.
  • The identified miRNA signature shows promise as a novel biomarker for IPF diagnosis.
  • Sputum exosomal miRNAs may serve as indicators of IPF disease severity.
Keywords:
idiopathic pulmonary fibrosisinterstitial fibrosis

More Related Videos

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

3.1K
Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.6K

Related Concept Videos

Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
885
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.7K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
543
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
978
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K